Technical Analysis for GSK - GlaxoSmithKline PLC

Grade Last Price % Change Price Change
B 37.75 0.16% 0.06
GSK closed up 0.16 percent on Friday, April 16, 2021, on 1.15 times normal volume. It was able to bounce off of its 200 day moving average, an important long-term support line.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Flat Up Up
Historical GSK trend table...

Date Alert Name Type % Chg
200 DMA Support Bullish 0.00%
Jack-in-the-Box Bullish Bullish Swing Setup 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Calm After Storm Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Above Upper BB Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Shooting Star Candlestick Bearish 0.16%
Lizard Bearish Bearish Day Trade Setup 0.16%
Older End-of-Day Signals for GSK ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

GlaxoSmithKline PLC Description

GlaxoSmithKline plc, together with its subsidiaries, discovers, develops, manufactures, and markets pharmaceutical products, over-the-counter medicines, and health-related consumer products worldwide. It offers pharmaceutical products in various therapeutic areas comprising respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, antibacterials, oncology and emesis, dermatology, rare diseases, immuno-inflammation, vaccines, and HIV. The company provides prescription medicines to treat a range of conditions, including infections, depression, skin conditions, asthma, heart and circulatory disease, and cancer. It also produces paediatric and adult vaccines to prevent a range of infectious diseases, including hepatitis A and B; diphtheria, tetanus, and whooping cough; measles, mumps, and rubella; polio; typhoid; influenza; and bacterial meningitis. In addition, it provides consumer health products in oral care, nutritional, total wellness, and skin health areas. The company's total wellness products include Panadol for the treatment of paracetamol-based treatment of headache and joint pain, fever, and cold symptoms; NicoDerm, NiQuitin CQ, and Nicabate for the treatment of nicotine withdrawal as an aid to quitting smoking; ENO Tums, a rapid relief antacid; and oral care products comprise Sensodyne for the prevention of dental sensitivity; Polident, Poligrip, and Corega to improve comfort of fitted dentures and to clean dentures; Aquafresh for the prevention of caries, gum disease, and bad breath; and Parodontax to help stop bleeding gums and gum health. Its nutrition products include Lucozade for energy and hydration; and Horlicks and Maxinutrition for nutrition; and skin health products comprise Physiogel, a face and body care product for dry, sensitive, and irritated skin, and Oilatum, a soothing treatment for eczema and dry skin conditions. The company was founded in 1935 and is headquartered in Brentford, the United Kingdom.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: Medicine Cancer Pharmaceutical Acid Drugs Infectious Diseases Pharmaceutical Products Medication Rare Diseases Inflammation Antibiotic Health Products Influenza Symptoms Asthma Dermatology HIV Nutrition Products Glaxosmithkline Depression Smoking Cough Wellness Products Fever Infections Smoking Cessation Headache Nicotine Oral Care Products Body Care Product Eczema Meningitis Paracetamol Antacid Hepatitis A Joint Pain Measles Consumer Health Products Mumps Rubella Tetanus

Is GSK a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 43.18
52 Week Low 33.26
Average Volume 6,004,278
200-Day Moving Average 37.66
50-Day Moving Average 35.62
20-Day Moving Average 36.37
10-Day Moving Average 36.49
Average True Range 0.57
ADX 16.27
+DI 40.27
-DI 16.61
Chandelier Exit (Long, 3 ATRs ) 36.55
Chandelier Exit (Short, 3 ATRs ) 37.21
Upper Bollinger Band 37.46
Lower Bollinger Band 35.28
Percent B (%b) 1.14
BandWidth 5.97
MACD Line 0.33
MACD Signal Line 0.20
MACD Histogram 0.1279
Fundamentals Value
Market Cap 94.7 Billion
Num Shares 2.51 Billion
EPS 0.99
Price-to-Earnings (P/E) Ratio 38.05
Price-to-Sales 2.06
Price-to-Book 4.88
PEG Ratio 11.18
Dividend 2.03
Dividend Yield 5.38%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 38.17
Resistance 3 (R3) 38.17 38.04 38.10
Resistance 2 (R2) 38.04 37.93 38.03 38.08
Resistance 1 (R1) 37.89 37.86 37.82 37.89 38.05
Pivot Point 37.76 37.76 37.72 37.75 37.76
Support 1 (S1) 37.61 37.65 37.55 37.61 37.45
Support 2 (S2) 37.48 37.58 37.48 37.42
Support 3 (S3) 37.33 37.48 37.40
Support 4 (S4) 37.33